Molecular principles of alternative treatment approaches for hormone-refractory prostate cancer [Molekulare grundlagen alternativer therapieansätze für das hormonrefraktäre prostatakarzinom]

被引:0
|
作者
Thelen P. [1 ,6 ]
Burfeind P. [2 ]
Schweyer S. [3 ]
Scharf J.-G. [4 ]
Wuttke W. [5 ]
Ringert R.-H. [1 ]
机构
[1] Urologische Klinik, Georg-August-Universität, Göttingen
[2] Institut Humangenetik, Georg-August-Universität, Göttingen
[3] Abteilung Pathologie, Georg-August-Universität, Göttingen
[4] Abteilung Gastroenterologie und Endokrinologie, Georg-August-Universität, Göttingen
[5] Abteilung Experimentelle Endokrinologie, Georg-August-Universität, Göttingen
[6] Urologische Klinik, Georg-August-Universität, 37075 Göttingen
来源
Der Urologe | 2007年 / 46卷 / 9期
关键词
Complementary and alternative medicine (CAM); Histone deacetylase inhibitors (HDACi); Phyto-oestrogens; Prostate cancer; RNA interference (RNAi);
D O I
10.1007/s00120-007-1452-0
中图分类号
学科分类号
摘要
Prostate cancer is more frequently diagnosed in men from Western countries than from Asian societies. Therefore, nutritional factors such as phyto-oestrogens from soya are considered to cause this prostate cancer prevention effect. As there is no curative therapy for hormone-refractory prostate cancer, new strategies are in demand which might include phyto-oestrogens or inhibitors of histone deacetylases. Both approaches have in common the potential to reduce the aberrant androgen receptor and IGF receptor signalling. Furthermore, invasiveness and acquired survival strategies of tumours can be diminished. Reduced tumour cell proliferation and PSA secretion coincide with altered gene expression in the aforementioned processes. In addition, selective knock-down of genes by RNA interference afforded functional analyses regarding impact and succession of expression events involved in the beneficial effects caused by phyto-oestrogens and histone deacetylase inhibitors. © 2007 Springer Medizin Verlag.
引用
收藏
页码:1271 / 1274
页数:3
相关论文
共 5 条
  • [1] Role of androgen receptors in hormone-refractory prostate cancer: Molecular basics and experimental therapy approaches [Die rolle des androgenrezeptors im hormonrefraktären prostatakarzinom: Molekulare grundlagen und experimentelle therapieansätze]
    Rinnab L.
    Hessenauer A.
    Schütz S.V.
    Schmid E.
    Küfer R.
    Finter F.
    Hautmann R.E.
    Spindler K.D.
    Cronauer M.V.
    [J]. Der Urologe, 2008, 47 (3): : 314 - 325
  • [2] Metastasizing hormone-refractory prostate cancer. Chemotherapy and new treatment approaches [Metastasiertes hormonrefraktäres prostatakarzinom. Chemotherapie und neue therapieansätze]
    Wierecky J.
    Bokemeyer C.
    [J]. Der Onkologe, 2007, 13 (8): : 726 - 731
  • [3] Molecular principles of alternative treatment approaches for hormone-refractory prostate cancer
    Thelen, P.
    Burfeind, P.
    Schweyer, S.
    Scharf, J.-G.
    Wuttke, W.
    Ringert, R.-H.
    [J]. UROLOGE, 2007, 46 (09): : 1271 - 1274
  • [4] Treatment options and side effects: The hormone refractory prostate cancer [Therapieoptionen und Nebenwirkungen: Das hormonrefraktäre Prostatakarzinom]
    Miller K.
    [J]. best practice onkologie, 2006, 1 (1) : 27 - 35
  • [5] Das hormonrefraktäre Prostatakarzinom – eine internistische HerausforderungThe hormone refractory prostate cancer – a challenge for the internal specialist
    Stefan Kudlacek
    Johannes G. Meran
    Dora Beke
    [J]. Wiener Medizinische Wochenschrift, 2007, 157 (7-8) : 145 - 148